Latest Strategy Changes News

Infotrust has finalized its acquisition of Canberra-based Catalyst Cyber, enhancing its foothold in federal government cyber security with a deal structured around performance-linked payments.

Brisbane Broncos Limited celebrated a landmark 2025 with premiership victories in both the NRL and NRLW, driving a 36% jump in net profit to $7.77 million and underpinning strong commercial growth.

Elanor Investors Group has finalised a $125 million recapitalisation with Rockworth Capital Partners, restructuring its debt and setting the stage for expansion in Asia. The move repaid existing facilities and bolstered working capital, while a Singapore acquisition awaits regulatory green light.

Electro Optic Systems (ASX: EOS) wraps up a three-year turnaround, reporting a $459 million order backlog despite a 27% revenue drop. The company expands its counter-drone and space control portfolio with the acquisition of the UK-based Interceptor business and a pending deal for MARSS, a European command-and-control software provider.

Lithium Plus Minerals has secured A$2.15 million through a discounted placement, backed by cornerstone investor Suzhou CATH and institutional buyers, to fund development and exploration at its Bynoe lithium project.

Multistack International has formalised the sale of nearly all its assets and liabilities to Hong Kong-based Willing Y Limited, marking a decisive end to its loss-making operations. The transaction hinges on shareholder and regulatory approvals, with completion targeted for June 30, 2026.

Krakatoa Resources has restructured its acquisition of the Zopkhito Antimony-Gold Project in Georgia, adopting a staged earn-in model that reduces upfront payments and prioritises capital deployment into exploration and development activities for 2026.

IRIS Metals has fortified its balance sheet with a A$5.5 million placement and is progressing towards an updated lithium-rubidium resource at Beecher while executing a farm-in deal for a tungsten project in Montana, reinforcing its diversified US critical minerals strategy.

Memphasys Limited has marked a milestone quarter with revenue surpassing A$100,000, driven by repeat orders and multi-year contracts, signalling its transition to a commercially focused biotech business.

K2 Asset Management has decided to wind down its K2 Australian Small Cap Hedge Fund Complex ETF after a strategic review found it unlikely to meet profitability targets. The closure paves the way for reallocating capital to higher-growth areas and streamlining product offerings.

Eden Innovations has unveiled EdenShield®, a new division focused on commercialising advanced carbon nanotube-enhanced materials and dual-fuel systems for defence and critical infrastructure, aiming to tap into a rapidly expanding global aerospace and defence market.

Proteomics International Laboratories has slashed a quarter of its workforce and appointed a new CFO amid a strategic pivot to commercial diagnostics, aiming to save over $1 million annually and sharpen execution.